# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Melius Research downgrades Heliogen (OTC:HLGN) from Buy to Hold.
Heliogen (NYSE:HLGN) reported quarterly losses of $(3.13) per share which beat the analyst consensus estimate of $(3.62) by 13....
Particle receiver prototype design verification advances Heliogen's 5MWe commercial-scale renewable power project
On Thursday, 369 companies hit new 52-week lows.
On Wednesday, 311 stocks hit new 52-week lows.